NCT04100460View on ClinicalTrials.gov

A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).

NAUnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

May 31, 2020

Conditions
Gastrointestinal Tolerance
Interventions
DIETARY_SUPPLEMENT

7.25 grams of Arabinoxylan leaf fiber extract

Participants are given 7.25 grams of Arabinoxylan daily

DIETARY_SUPPLEMENT

14.5 grams of Arabinoxylan leaf fiber extract

Participants are given 14.5 grams of Arabinoxylan daily

DIETARY_SUPPLEMENT

Control - No Arabinoxylan

Participants are given no Arabinoxylan

Sponsors

Lead Sponsor

Comet Bio Inc.
All Listed Sponsors
collaborator

Biofortis, Merieux NutriSciences

INDUSTRY

lead

Comet Bio Inc.

INDUSTRY

NCT04100460 - A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract). | Biotech Hunter | Biotech Hunter